Daniel M. Junius

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
7 years
Director since
2023

7 years of board service in total across 2 boards, counting each seat separately. Longest: IDEXX Laboratories Inc., 3 years.

3 years · Since 2023
3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Nov 4, 2026 IDEXX Laboratories Inc. Open-market sale −700 $705.78 $494,046
Nov 4, 2026 IDEXX Laboratories Inc. Open-market sale −500 $701.69 $350,843
May 7, 2026 IDEXX Laboratories Inc. Option exercise +257 — —
May 13, 2025 IDEXX Laboratories Inc. Option exercise +1,404 $245.79 $345,089
May 13, 2025 IDEXX Laboratories Inc. Option exercise +1,279 $283.59 $362,712
May 13, 2025 IDEXX Laboratories Inc. Open-market sale −2,683 $506.41 $1,358,698
May 6, 2025 IDEXX Laboratories Inc. Option exercise +262 — —
Mar 29, 2024 Crescent Biopharma Inc. Grant or award +5,209 $3.00 $15,627
Jan 30, 2024 IDEXX Laboratories Inc. Grant or award +14 $521.03 $7,294
Oct 30, 2023 IDEXX Laboratories Inc. Grant or award +19 $396.39 $7,531
Jul 28, 2023 IDEXX Laboratories Inc. Grant or award +14 $552.78 $7,739
May 10, 2023 Crescent Biopharma Inc. Open-market purchase +30,000 $1.56 $46,800
Apr 28, 2023 IDEXX Laboratories Inc. Grant or award +13 $492.16 $6,398
Feb 16, 2023 IDEXX Laboratories Inc. Option exercise +2,187 $206.62 $451,878
Feb 16, 2023 IDEXX Laboratories Inc. Open-market sale −2,187 $511.68 $1,119,044

Questions about Daniel M. Junius

What boards is Daniel M. Junius on?

Daniel M. Junius sits on the boards of Crescent Biopharma Inc. and IDEXX Laboratories Inc.

How long has Daniel M. Junius served on boards?

Our records show at least 7 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.